Category: Ovarian
Accelerating Approval Pathway For Phase III Ovarian Cancer Trial A late-stage biotech was developing a combination therapy for a rare form of ovarian cancer. It is challenging to diagnose, difficult to treat due to its chemo-resistance, and at the time, there were no approved treatments specifically for this indication. Read Now
Developing Cutting-edge Treatments for Ovarian Cancer Ovarian cancer is the second most common gynecological cancer worldwide and carries the highest mortality Read Now
Global Full-service Phase III Ovarian Cancer Study Catalyst Oncology succeeds in delivering for late clinical-stage oncology biotech. While the biotech had experience Read Now